Is Chicmax Cosmetic profitable?

Yes. Chicmax reported FY2025 net profit of RMB1.103 billion, up 41.1% year over year, on revenue of RMB9.178 billion, up 35.1%, per its March 6, 2026 positive profit alert filed with HKEX.

What is Chicmax's biggest competitor?

Proya Cosmetics is China's largest domestic cosmetics company, with over RMB10 billion revenue in 2024, and is widely seen as Chicmax's top domestic rival, ahead of L'Oreal backed Chando, per April 2026 reporting.

Could AI replace Chicmax's sales model?

Chicmax relies heavily on Douyin livestreaming and KOLs for sales. Industry-wide, AI virtual hosts generated a documented $7 million single session in June 2025, and rival Marubi claims about 15% CAC reduction from AI streamers, though Chicmax's own AI use is unconfirmed.

Is Chicmax the same company as Chando?

No. Chicmax (HKEX: 2145) and Chando are separate, competing Chinese cosmetics companies. Chicmax's flagship is KANS; Chando is L'Oreal backed and ranked China's third largest domestic player with RMB5.3 billion revenue in 2025.

How dependent is Chicmax on a single brand?

Very dependent. Chicmax's KANS brand generated RMB3,344.0 million in 1H2025, about 81% of group revenue, up 14.3% year over year, per the company's August 28, 2025 interim results filing.

Is Chicmax stock a safe investment right now?

Mixed signals: despite FY2025 revenue growth of 35.1% and net profit growth of 41.1%, Chicmax's stock fell roughly 62% over the trailing year as of July 2026, per FT Markets, suggesting investor skepticism about durability.

Consumer brands · China

Chicmax Cosmetic Co., Ltd.

Chinese cosmetics maker behind KANS and Baby Elephant, sold mainly via Douyin livestreams.

Losing its protection

Assessed 26 July 2026 · Evidence as of 26 July 2026

The structural protection is eroding.

On the recordSince 26 July 2026 · Checkable from mid and late 2026 · Every call on the record Checkpoint: 618 and Double 11 2026 sales festivals, where KANS Douyin GMV share versus Proya will show if the gap is closing

The call

Chicmax is growing fast and profitably today, but it leans on one brand and one platform playbook that rivals with more money are copying.

Chicmax sells cosmetics through livestreaming on Douyin, China's short-video platform, and has two main brands: KANS and Baby Elephant. The company is profitable and growing fast, but it is not hard to copy because competitors like Proya, Chando (backed by L'Oréal), and Marubi are already using the same livestreaming playbook, and AI-powered virtual hosts are starting to replace human influencers and lower the cost of finding customers. The one thing that could change the picture is whether Chicmax can grow its smaller brands like Newpage fast enough to stop relying so heavily on KANS (which makes up 81% of sales) and whether livestreaming stays expensive enough to keep working as a business advantage.

Why

AI pressure: AI livestream hosts and virtual influencers replacing human KOLs on Douyin. Rivals like Marubi claim AI hosts cut customer acquisition costs, threatening to erase Chicmax's livestream cost edge. Could AI do the core job? Only partly.

Bigger players: L'Oréal-backed Chando and Proya. Proya already outsells Chicmax and Chando, backed by L'Oréal capital, copies the same Douyin playbook with deeper pockets. Could a giant copy it? Probably.

What protects it. Two decades of KANS brand trust and a profitable, fast-growing base give it room, but little else is proprietary.

What would change this call

KANS Douyin GMV share vs Proya during June 18 and Double 11 2026 sales festivals. Shows whether Chicmax is losing ground in its core sales channel to Proya.
Outcome and capital use of Chando's Hong Kong IPO refiled April 2026. Shows whether L'Oréal-backed Chando gains funding to scale competing livestream operations.
Share of Chicmax total revenue from newpage and Baby Elephant in FY2026 results. Shows whether Chicmax reduces its 81% dependence on the single KANS brand.

Key numbers

FY2025 revenue RMB 9.18B, up 35.1% (2025-12-31)
KANS brand is 81% of group revenue (2025-06-30)
newpage brand revenue up 146.5% to RMB 397M (2025-06-30)

Named risks

KANS single brand accounts for 81% of revenue as of 1H2025, concentrating execution risk. Severity: high
AI virtual livestream hosts commoditizing Douyin customer acquisition costs across sector. Severity: medium
Stock down 62% year over year despite strong revenue growth signals market distrust of moat durability. Severity: high
Dual competitor IPOs (Chando, Proya second listing) could intensify capital and competitive arms race. Severity: medium
China NMPA regulatory tightening and consumption cooling cited as sector headwinds. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Proya Cosmetics	losing to	Proya over RMB10B revenue in 2024 vs Chicmax RMB9.178B in 2025, remains larger
Chando (L'Oreal backed)	contesting	Chando refiled Hong Kong IPO April 2026, RMB5.3B revenue 2025, +15.2% YoY
Marubi	gaining on	Marubi claims ~15% CAC reduction from AI livestreamers per April 2026 vendor analysis
L'Oreal, Estee Lauder, Shiseido	gaining on	Domestic brands held 57% of China cosmetics market in 2025, pressuring global incumbents

Questions people ask

Is Chicmax Cosmetic profitable?: Yes. Chicmax reported FY2025 net profit of RMB1.103 billion, up 41.1% year over year, on revenue of RMB9.178 billion, up 35.1%, per its March 6, 2026 positive profit alert filed with HKEX.
What is Chicmax's biggest competitor?: Proya Cosmetics is China's largest domestic cosmetics company, with over RMB10 billion revenue in 2024, and is widely seen as Chicmax's top domestic rival, ahead of L'Oreal backed Chando, per April 2026 reporting.
Could AI replace Chicmax's sales model?: Chicmax relies heavily on Douyin livestreaming and KOLs for sales. Industry-wide, AI virtual hosts generated a documented $7 million single session in June 2025, and rival Marubi claims about 15% CAC reduction from AI streamers, though Chicmax's own AI use is unconfirmed.
Is Chicmax the same company as Chando?: No. Chicmax (HKEX: 2145) and Chando are separate, competing Chinese cosmetics companies. Chicmax's flagship is KANS; Chando is L'Oreal backed and ranked China's third largest domestic player with RMB5.3 billion revenue in 2025.
How dependent is Chicmax on a single brand?: Very dependent. Chicmax's KANS brand generated RMB3,344.0 million in 1H2025, about 81% of group revenue, up 14.3% year over year, per the company's August 28, 2025 interim results filing.
Is Chicmax stock a safe investment right now?: Mixed signals: despite FY2025 revenue growth of 35.1% and net profit growth of 41.1%, Chicmax's stock fell roughly 62% over the trailing year as of July 2026, per FT Markets, suggesting investor skepticism about durability.

Timeline

2026-04-16Chicmax ESG Report 2025 discloses 61 new patent applications, 49 granted patents
2026-04-08Reporting places Chicmax above Chando, behind Proya, among China's top domestic cosmetics firms
2026-03-06Chicmax issues positive profit alert for FY2025: revenue RMB9.178B, net profit RMB1.103B
2025-08-28Chicmax interim results show 1H2025 revenue RMB4,108.0M, KANS at 81% of revenue
2025-06-23AI generated virtual livestream hosts documented driving $7M single sales session in China
2024-04-25Chicmax Annual Report 2023 shows FY2023 revenue RMB4,190.7M
2022-12-22Chicmax completes Hong Kong IPO, raising approximately HK$1.1 billion gross
2020-12-24Company converts from limited liability company to joint stock company

Revision history

26 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

PVH VF Kering